Investment Banking
Healthcare & Life Sciences

Salem Partners' John Dyett is interviewed and quoted by Paul Sullivan of The New York Times regarding his work on the Adams Therapeutics deal

Published on
February 8, 2012

Summary

IN late 2003, Judith M. von Seldeneck walked into her boss’s office with a bold proposition: sell me back my old firm for a lot less than you paid for it five years ago, she told him, and I’ll be on my way.

Her boss agreed to the proposal.

Team Members Involved

Meet the talented individuals who brought their expertise and dedication to this project. Their collaboration, insight, and commitment to excellence were instrumental in delivering impactful results for our clients.

John Dyett
Co-Founder and Managing Director

jdyett@salempartners.com

Related News Articles

Stay updated with the latest industry news.

Related News Articles

Stay updated with the latest industry news.

Have questions? Our team is here to help

Whether you're seeking guidance on a complex transaction, exploring investment banking possibilities, or looking for wealth management strategies, our team is here to help.

Stay in touch

Provide your email to join our distribution list. By providing your email you consent to receive emails from Salem Partners Wealth Management.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.